Loading...
•
Aug 31, 2024
Walgreens Q4 2024 Earnings Report
Walgreens' Q4 2024 earnings met expectations, with the company announcing a footprint optimization program.
Key Takeaways
Walgreens Boots Alliance reported a 6.0% increase in fourth-quarter sales to $37.5 billion, but experienced a net loss of $3.0 billion, or $3.48 per share, compared to a net loss of $180 million, or $0.21 per share in the year-ago quarter. Adjusted EPS was $0.39, a 40.8% decrease on a constant currency basis. The company announced a footprint optimization program targeting approximately 1,200 closures over the next three years.
Fourth quarter sales increased 6.0% year-over-year to $37.5 billion, up 6.1% on a constant currency basis.
Adjusted earnings per share (Adjusted EPS) was $0.39, down 40.8 percent on a constant currency basis.
Net loss in the fourth quarter was $3.0 billion compared to a net loss of $180 million in the year-ago quarter.
Announcing footprint optimization program targeting approximately 1,200 closures over the next three years, including approximately 500 closures in fiscal 2025.
Walgreens
Walgreens
Walgreens Revenue by Segment
Revenue by Segment
U.S. Pharmacy Revenue
CapyFin.comInternational Revenue
CapyFin.comU.S. Healthcare Revenue
CapyFin.com Forward Guidance
Walgreens Boots Alliance expects adjusted EPS of $1.40 to $1.80 for fiscal year 2025.
Positive Outlook
- Growth in U.S. Healthcare
- Growth in International
Challenges Ahead
- Decline in U.S. Retail Pharmacy
- Higher adjusted effective tax rate
- Lower contributions from sale-leaseback
- Lower contributions from Cencora earnings
Revenue & Expenses
Visualization of income flow from segment revenue to net income